# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Cumberland to expand its gastroenterology offerings with the market-leading Helicobacter pylori therapyNASHVILLE, Tenn., Oct. ...
The deal aims to accelerate Talicia's entry into new Middle East markets Under the terms of the agreement RedHill will rece...
Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday's pre-market session. The ...
The New York Supreme Court has, on appeal, upheld its original summary judgment ruling in favor of RedHillThe New York Supreme ...
Redhill Biopharma (NASDAQ:RDHL) reported $4.079 million in sales this quarter. This is a 58.59 percent increase over sales of $...